Kasperk C, Meeder P J, Nöldge G, Wiedenhöfer B, Ewerbeck R, Bardenheuer H, Grafe I, Huber F-X, Nawroth P
Exp Clin Endocrinol Diabetes. 2010 Feb;118(2):71-4. doi: 10.1055/s-0030-1247517. Epub 2010 Jan 26.
Osteoporotic vertebral fractures and pathological vertebral lesions are frequent clinical situations causing severe back pain. The pharmacological treatment of the underlying disease and the analgetic treatment of the associated back pain usually do not rid the patient's back pain completely and are insufficient to prevent the fracture-weakened vertebral body from further fracturing with long term consequences for the biomechanical competence of the entire spine. In the last 10 years the minimal invasive treatment options vertebroplasty (VP) and balloon kyphoplasty (BK) have spread quickly because these procedures appeared to be promising treatments to stop the fracture and vertebral lesion associated back pain and to internally stabilize a fractured vertebral body. Numerous published reports on VP and BK appeared to support the notion of an immediate and lasting pain reduction after VP and BK in additon to a prevention of further fracturing of the treated vertebrae. The first three randomized controlled and partly blinded trials have been published this year. Two of these trials demonstrate that VP does not result in a better pain control than a sham operation whereas BK was shown to reduce back pain due to verterbal fractures for at least 12 months. Considering that more than 1.5 million people world-wide have been treated with VP and BK until now this work discusses the recent trials and suggests clinical and academic consequences on the basis of the most recent evidence.
骨质疏松性椎体骨折和病理性椎体病变是导致严重背痛的常见临床情况。对基础疾病的药物治疗以及对相关背痛的止痛治疗通常无法完全消除患者的背痛,且不足以防止骨折削弱的椎体进一步骨折,从而对整个脊柱的生物力学能力产生长期影响。在过去十年中,微创治疗方法椎体成形术(VP)和球囊后凸成形术(BK)迅速普及,因为这些手术似乎是阻止与骨折和椎体病变相关的背痛以及使骨折椎体内部稳定的有前景的治疗方法。众多关于VP和BK的已发表报告似乎支持了这样的观点,即VP和BK术后能立即且持久地减轻疼痛,此外还能预防治疗椎体的进一步骨折。今年已发表了前三项随机对照且部分设盲的试验。其中两项试验表明,VP在疼痛控制方面并不比假手术更好,而BK被证明能减轻因椎体骨折引起的背痛至少12个月。鉴于到目前为止全球已有超过150万人接受了VP和BK治疗,本文讨论了近期的试验,并根据最新证据提出了临床和学术方面的结论。